ICA9 Report: Some Other Drugs

ICA9 Report: Some Other Drugs

Being Alive Newsletter, Being Alive/Los Angeles - July 1993
Mark Katz, MD and reported by Jim Stoecker

Compound Q continues to be studied in San Francisco. Study participants are using a much higher dose than what was common a few years back. People appear to be tolerating this high dosage and dose escalation studies are going forward. For the study group, CD4 levels have remained stable for over two years.

A German study reported that acyclovir may slow down the progression to AIDS. Researchers have long suspected that this drug holds both CMV and herpes in check. By suppressing the cytomegalo and herpes viruses, acyclovir may remove a cofactor of disease progression.
930700
BA930711

AEGiS is made possible through unrestricted grants from Roxane Laboratories, the National Library of Medicine, and donations from users like you. Always watch for outdated information. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1993 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1993. AEGIS.